Charles River ($CRL) 8‑K (Feb 18, 2026): issued press release with Q4 and FY results for period ended Dec…

Filed with the SEC on February 18, 2026 · Summarized by InvestorsBot

Charles River ($CRL) 8‑K (Feb 18, 2026): issued press release with Q4 and FY results for period ended Dec 27, 2025; press release attached as an exhibit. 📢📈 #earnings #biotech

Press release includes PSLRA "safe harbor" — contains forward‑looking statements and refers investors to risks in CRL's SEC filings. 🔍🧾 $CRL #investing #regulation

8‑K notes the press release is not "filed" for purposes of Section 18 of the Exchange Act and won't be incorporated by reference unless expressly stated. ⚖️ $CRL #corpsec #compliance

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Feb 25, 2026: $CRL agreed to sell its CDMO and Cell Solutions businesses to GI Partners for primarily…

8-K · February 25, 2026

Charles River ($CRL) filed an 8-K (Item 9.01) on Feb 18, 2026 — Exhibits: 99.1 press release (dated Feb…

8-K · February 18, 2026

Charles River ($CRL) filed an 8‑K (Item 9.01) disclosing an Employment Offer Letter with Glenn Coleman…

8-K · February 18, 2026

Charles River names Glenn Coleman Corporate Executive VP & CFO, tentative start April 6, 2026.

8-K · February 18, 2026

Charles River ($CRL): Q4 DSA net book-to-bill ~1.1x as demand improved through H2 2025, led by small/mid…

8-K · January 13, 2026

Charles River ($CRL) presenting at J.P.

8-K · January 13, 2026